BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 26011100)

  • 1. Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co-occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study.
    Ilo D; Raluy-Callado M; Graham-Clarke P; Sadasivan R; Birt J; Donaldson R; Zhu E; Kirby MG; Neasham D
    Int J Clin Pract; 2015 Aug; 69(8):853-62. PubMed ID: 26011100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erectile disfunction and benign prostatic hyperplasia - causal relation or coincidence?].
    Gasser T
    Ther Umsch; 2010 Mar; 67(3):145-7. PubMed ID: 20235043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction.
    McVary K; Foley KA; Long SR; Sander S; Curtice TG; Shah H
    Curr Med Res Opin; 2008 Mar; 24(3):775-84. PubMed ID: 18237458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction with or without coexisting benign prostatic hyperplasia in the general US population: analysis of US National Health and Wellness Survey.
    Foster SA; Annunziata K; Shortridge EF; Freedman D; Viktrup L
    Curr Med Res Opin; 2013 Dec; 29(12):1709-17. PubMed ID: 23971532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Approaches to medical management of patients with high risk of progressing of benign prostatic hyperplasia depending on concomitant erectile dysfunction].
    Kamalov AA; Takhirzade AM
    Urologiia; 2018 Jul; (3):70-77. PubMed ID: 30035422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current approaches to conservative treatment of men with concomitant benign prostatic hyperplasia and erectile dysfunction].
    Kamalov AA; Takhirzade AM
    Urologiia; 2017 Dec; (6):160-163. PubMed ID: 29376615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy for benign prostatic hyperplasia: a review.
    Van Asseldonk B; Barkin J; Elterman DS
    Can J Urol; 2015 Oct; 22 Suppl 1():7-17. PubMed ID: 26497339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
    Scranton RE; Goldstein I; Stecher VJ
    J Sex Med; 2013 Feb; 10(2):551-61. PubMed ID: 23153075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Incident Antidepressant-Treated Depression Associated with Use of 5α-Reductase Inhibitors Compared with Use of α-Blockers in Men with Benign Prostatic Hyperplasia: A Population-Based Study Using the Clinical Practice Research Datalink.
    Hagberg KW; Divan HA; Nickel JC; Jick SS
    Pharmacotherapy; 2017 May; 37(5):517-527. PubMed ID: 28295443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatments of erectile dysfunction combined with lower urinary tract symptoms associated with benign prostatic hyperplasis].
    Jin Z; Xin ZC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):632-5. PubMed ID: 21844982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Co-occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results From the National Health and Nutrition Examination Survey.
    Egan KB; Burnett AL; McVary KT; Ni X; Suh M; Wong DG; Rosen RC
    Urology; 2015 Sep; 86(3):570-80. PubMed ID: 26210004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Therapy in Men's Health: Hypogonadism, Erectile Dysfunction, and Benign Prostatic Hyperplasia.
    Berkseth KE; Thirumalai A; Amory JK
    Med Clin North Am; 2016 Jul; 100(4):791-805. PubMed ID: 27235615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Treated with Finasteride and Alpha Blocker Combination Therapy Versus Alpha Blocker Monotherapy in China: An Analysis of Electronic Medical Record Data.
    Fu Y; Han S; Wang L; Gao W; Wu E; Cao X; Wang J
    Adv Ther; 2018 Aug; 35(8):1191-1198. PubMed ID: 30014350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
    Brock GB; McVary KT; Roehrborn CG; Watts S; Ni X; Viktrup L; Wong DG; Donatucci C
    J Urol; 2014 Feb; 191(2):405-11. PubMed ID: 24096120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of benign prostatic hyperplasia].
    Oelke M; Martinelli E
    Urologe A; 2016 Jan; 55(1):81-94; quiz 95-6. PubMed ID: 26676726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phosphodiesterase type 5 inhibitors for lower urinary tract symptoms.
    Miller MS
    Ann Pharmacother; 2013 Feb; 47(2):278-83. PubMed ID: 23386068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
    Morlock R; Goodwin B; Gomez Rey G; Eaddy M
    Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.
    Frederick LR; Cakir OO; Arora H; Helfand BT; McVary KT
    J Sex Med; 2014 Oct; 11(10):2546-53. PubMed ID: 25059314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.